|
||
| |||||||
|
Rubicon Genomics, Inc. today announced the launch of their GenomePlex™ whole genome amplification (WGA) point of use kit Ann Arbor, MI, November 10,
2003—Rubicon Genomics, Inc. today announced the launch of their GenomePlex™
whole genome amplification (WGA) point of use kit applications in the research
market. The GenomePlex kits will
complement Rubicon’s WGA in-house service business that was launched earlier
this year. Rubicon’s proprietary
in-vitro method to convert very small amounts of genomic DNA into OmniPlex™
amplifiable libraries has powerful applications in research, pharmacogenomics,
molecular diagnostics, and forensics. The GenomePlex kits provide the
same high quality results as the Rubicon WGA services, but focus on the most
common samples sizes and concentrations. They
are designed for ready to use WGA at pharmaceutical companies, institutions and
universities, who are unable to use the WGA custom amplification services
because of time, cost, or prohibition of export of patient samples. The first launched GenomePlex
kits contain proprietary reagents and protocol sufficient for 50 WGA reactions,
each generating up to 10 mg of amplified DNA in less than 4 hours. The
GenomePlex protocol is simple yet robust and the amplified DNA has been
validated on multiple high throughput genotyping and sequencing platforms.
Unlike most existing WGA methods, amplification product is not detected
using GenomePlex in the absence of input DNA.
The high quality of GenomePlex amplified DNA will support high quality
genetic analysis. “Rubicon continues to execute
its strategy to become the industry standard for managing genetic resources,”
said Fred G. Beyerlein, president and chief executive officer of Rubicon.
“With the roll out of our GenomePlex amplification kits we are looking
to reach another tier of our target market and put our products in the hands of
the actual users. The knowledge and
experience we have gained in our service business, in cooperation with our
clients, has enabled us to put a superior product on the market”. Extending from the success of
the WGA services, Rubicon is committed to providing the best products and
services in whole genome amplification by making GenomePlex kits available for
the general research community. GenomePlex
kits offers end users an easy to use, rapid turnaround (less than 4 hours) means
to generate high quality amplified DNA sufficient for any genomic research.
For details of our product or service orderings, please visit Rubicon
website: www.rubicongenomics.com
or contact Rubicon at Telephone: (734)-677-6219, Facsimile: (734)-477-9902 or
Email: kits@rubicongenomics.com. About
Rubicon Genomics, Inc. Contact:
Rubicon Genomics, Inc. Euro RSCG Life NRP Fred
G. Beyerlein, President and CEO Jeannine
Medeiros, Vice President (734) 677-2890 (415) 901-3709 |
|
| ||||||||